Empagliflozin Relaxes Resistance Mesenteric Arteries by Stimulating Multiple Smooth Muscle Cell Voltage-Gated K(+) (K(V)) Channels

The antidiabetic drug empagliflozin is reported to produce a range of cardiovascular effects, including a reduction in systemic blood pressure. However, whether empagliflozin directly modulates the contractility of resistance-size mesenteric arteries remains unclear. Here, we sought to investigate i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan, Ahasanul, Hasan, Raquibul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509755/
https://www.ncbi.nlm.nih.gov/pubmed/34639181
http://dx.doi.org/10.3390/ijms221910842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509755/
https://www.ncbi.nlm.nih.gov/pubmed/34639181
http://dx.doi.org/10.3390/ijms221910842

Ejemplares similares